PPARγ/PGC1α signaling as a potential therapeutic target for mitochondrial biogenesis in neurodegenerative disorders
S Jamwal, JK Blackburn, JD Elsworth - Pharmacology & Therapeutics, 2021 - Elsevier
Neurodegenerative diseases represent some of the most devastating neurological
disorders, characterized by progressive loss of the structure and function of neurons. Current …
disorders, characterized by progressive loss of the structure and function of neurons. Current …
[HTML][HTML] PPARγ as a therapeutic target to rescue mitochondrial function in neurological disease
There is increasing evidence for the involvement of mitochondrial dysfunction and oxidative
stress in the pathogenesis of many of the major neurodegenerative and neuroinflammatory …
stress in the pathogenesis of many of the major neurodegenerative and neuroinflammatory …
RETRACTED: Activation of the PPAR/PGC-1α Pathway Prevents a Bioenergetic Deficit and Effectively Improves a Mitochondrial Myopathy Phenotype
T Wenz, F Diaz, BM Spiegelman, CT Moraes - Cell metabolism, 2008 - cell.com
Neuromuscular disorders with defects in the mitochondrial ATP-generating system affect a
large number of children and adults worldwide, but remain without treatment. We used a …
large number of children and adults worldwide, but remain without treatment. We used a …
Mitochondrial biogenesis in neurodegeneration
PA Li, X Hou, S Hao - Journal of neuroscience research, 2017 - Wiley Online Library
Mitochondria play a key role in energy production, calcium homeostasis, cell survival, and
death. Adverse stimulations including neurodegenerative diseases may result in …
death. Adverse stimulations including neurodegenerative diseases may result in …
PGC-1α, mitochondrial dysfunction, and Huntington's disease
The constant high energy demand of neurons makes them rely heavily on their
mitochondria. Dysfunction of mitochondrial energy metabolism leads to reduced ATP …
mitochondria. Dysfunction of mitochondrial energy metabolism leads to reduced ATP …
PGC-1α at the intersection of bioenergetics regulation and neuron function: from Huntington's disease to Parkinson's disease and beyond
T Tsunemi, AR La Spada - Progress in neurobiology, 2012 - Elsevier
Neurons are specialized cells with unique features, including a constant high demand for
energy. Mitochondria satisfy this constant demand, and are emerging as a central target for …
energy. Mitochondria satisfy this constant demand, and are emerging as a central target for …
PGC-1α sparks the fire of neuroprotection against neurodegenerative disorders
J Lv, S Jiang, Z Yang, W Hu, Z Wang, T Li… - Ageing research reviews, 2018 - Elsevier
Recently, growing evidence has demonstrated that peroxisome proliferator activated
receptor γ (PPARγ) coactivator-1α (PGC-1α) is a superior transcriptional regulator that acts …
receptor γ (PPARγ) coactivator-1α (PGC-1α) is a superior transcriptional regulator that acts …
PPAR: a therapeutic target in Parkinson's disease
RK Chaturvedi, MF Beal - Journal of neurochemistry, 2008 - Wiley Online Library
Parkinson's disease (PD) is a progressive and chronic neurodegenerative disorder,
characterized by progressive loss of dopaminergic neurons in substantia nigra. The etiology …
characterized by progressive loss of dopaminergic neurons in substantia nigra. The etiology …
PPARγ and PGC-1α as therapeutic targets in Parkinson's
The peroxisome proliferator-activated receptor gamma (PPARγ) is a ligand-activated
transcriptional factor that belongs to the nuclear hormone receptor superfamily. PPARγ was …
transcriptional factor that belongs to the nuclear hormone receptor superfamily. PPARγ was …
Peroxisom proliferator-activated receptor-γ coactivator-1α in neurodegenerative disorders: A promising therapeutic target
YN Yang, MQ Zhang, FL Yu, B Han, MY Bao… - Biochemical …, 2023 - Elsevier
Neurodegenerative disorders (NDDs) are characterized by progressive loss of selectively
vulnerable neuronal populations and myelin sheath, leading to behavioral and cognitive …
vulnerable neuronal populations and myelin sheath, leading to behavioral and cognitive …
相关搜索
- pgc 1α huntington's disease
- pgc 1α neurodegenerative disorders
- mitochondrial biogenesis neurodegenerative disorders
- pgc 1α therapeutic targets
- receptor γ neurodegenerative disorders
- pgc 1α mitochondrial dysfunction
- receptor γ coactivator 1α
- pgc 1α neuron function
- mitochondrial function therapeutic target
- neurological disease therapeutic target
- pgc 1β mitochondrial density
- pgc 1α bioenergetic deficit
- pgc 1α myopathy phenotype
- coactivator 1α neurodegenerative disorders
- pgc 1α mitochondrial density
- pgc 1α parkinson's disease